fbpx Back to Top

Bladder Cancer

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


For current information, log in to FundFinder.



Assistance Amount

$3,400 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for bladder cancer.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product.   
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Abraxane (paclitaxel protein-bound)
  • Adriamycin (doxorubicin hcl)
  • Adrucil (fluorouracil)
  • Alimta (pemetrexed disodium)
  • Balversa (erdafitinib)
  • Bavencio (avelumab)
  • Bcg (tice Strain) (bcg live)
  • Bcg Vaccine (tice Strain) (bcg vaccine, live/pf)
  • Carboplatin (carboplatin)
  • Cisplatin (cisplatin)
  • Docefrez (docetaxel)
  • Docetaxel (docetaxel)
  • Doxil (doxorubicin hcl pegylated liposomal)
  • Doxorubicin Hcl (doxorubicin hcl)
  • Doxorubicin Hcl Liposome (doxorubicin hcl pegylated liposomal)
  • Etoposide (etoposide)
  • Fluorouracil (fluorouracil)
  • Gemcitabine Hcl (gemcitabine hcl)
  • Gemzar (gemcitabine hcl)
  • Ifex (ifosfamide)
  • Ifosfamide (ifosfamide)
  • Ifosfamide-mesna (ifosfamide/mesna)
  • Imfinzi (durvalumab)
  • Keytruda (pembrolizumab)
  • Leucovorin Calcium (leucovorin calcium)
  • Lipodox (doxorubicin hcl pegylated liposomal)
  • Methotrexate (methotrexate sodium)
  • Mitomycin (mitomycin)
  • Mitomycin-sterile Water (mitomycin)
  • Opdivo (nivolumab)
  • Oxaliplatin (oxaliplatin)
  • Paclitaxel (paclitaxel)
  • Padcev (enfortumab vedotin-ejfv)
  • Paraplatin (carboplatin)
  • Taxotere (docetaxel)
  • Tecentriq (atezolizumab)
  • Tepadina (thiotepa)
  • Thiotepa (thiotepa)
  • Trexall (methotrexate sodium)
  • Valrubicin (valrubicin)
  • Valstar (valrubicin)
  • Vinblastine Sulfate (vinblastine sulfate)
  • Xatmep (methotrexate)

Diagnosis Codes:

ICD-10: C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C67.9


About the Disease:

Bladder cancer is a type of cancer with abnormal, uncontrolled growth in the cells of the bladder. It affects the exocrine system. Subtypes include transitional cell carcinoma and urothelial carcinoma.


Source: National Institutes of Health